Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics

Author： Nenadić Ilija   Staber Janine   Dreier Susanne   Simons Guus   Schildgen Verena   Brockmann Michael   Schildgen Oliver  

Publisher： MDPI

E-ISSN： 2072-6694|9|7|88-88

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.7, 2017-07, pp. : 88-88

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologically Optimized Radiation Therapy

By Brahme Anders   Nilsson Johan   Belkic Dzevad  

Acta Oncologica, Vol. 40, Iss. 6, 2001-11 ,pp. : 725-734

Informa Healthcare

Access to resources Recommend Favorite

Radioactive Isotopes in Physiology, Diagnostics and Therapy

By Dale W.M.  

International Journal of Radiation Biology, Vol. 4, Iss. 5, 1962-02 ,pp. : 535-535

Informa Healthcare

Access to resources Recommend Favorite

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC

By Lee Jay M   Mao Jenny T   Krysan Kostyantyn   Dubinett Steven M  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 149-153

Future Medicine

Access to resources Recommend Favorite

Promotion of Optimized Protein Therapy by Bioconjugation as a Polymeric DDS

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 3, 2006-05 ,pp. : 251-258

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy for Cancer: Integrating Diagnostics and Therapeutics

By Jeffrey S. Ross  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite